Ranked All-Publication list   Historiographs Glossary  HistCite Guide  About
Fri Aug 4 16:36:35 2006

Complete replication of hepatitis C virus in cell culture
Lindenbach BD, Evans MJ, Syder AJ, et al.
SCIENCE 309 (5734): 623-626 JUL 22 2005
and the citing papers
Nodes: 75, Authors: 371, Journals: 31, Cited References: 2431, Words: 336
Yearly output  |  Document Type  |  Language  |  Institution  |  Institution with Subdivision  |  Country
Collection span: 2005 - 2006
View: Overview   Sorted by date.

#LCRNCRNode / Date / Journal / AuthorLCSGCS
102720 2005 JUL 22 SCIENCE 309 (5734): 623-626
Lindenbach BD; Evans MJ; Syder AJ; Wolk B; Tellinghuisen TL; et al.
Complete replication of hepatitis C virus in cell culture
7474
213912 2005 AUG 18 NATURE 436 (7053): 930-932
Chisari FV
Unscrambling hepatitis C virus-host interactions
39
3110013 2005 AUG 18 NATURE 436 (7053): 933-938
Lindenbach BD; Rice CM
Unravelling hepatitis C virus replication from genome to function
715
417214 2005 AUG 18 NATURE 436 (7053): 961-966
Houghton M; Abrignani S
Prospects for a vaccine against the hepatitis C virus
16
519115 2005 AUG 18 NATURE 436 (7053): 967-972
Feld JJ; Hoofnagle JH
Mechanism of action of interferon and ribavirin in treatment of hepatitis C
315
61621 2005 SEP 12 SCIENTIST 19 (17): 29-30
Jonietz E
How does your virus grow?
00
71102 2005 SEP 19 CHEMISTRY & INDUSTRY (18): 22-24
Strosberg D; Burnet M
The molecular approach
00
81317 2005 OCT [15] JOURNAL OF HEPATOLOGY 43 (4): 553-555
Perelson AS; Ribeiro RM
Mutagenic effects of ribavirin in vivo
02
913216 2005 OCT 20 NATURE 437 (7062): 1167-1172
Meylan E; Curran J; Hofmann K; Moradpour D; Binder M; et al.
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
641
101161 2005 NOV [15] AMERICAN JOURNAL OF PATHOLOGY 167 (5): 1189-1191
Moore K; Dusheiko G
Opiate abuse and viral replication in hepatitis C
00
#LCRNCRNode / Date / Journal / AuthorLCSGCS
111345 2005 NOV [15] JOURNAL OF CLINICAL MICROBIOLOGY 43 (11): 5679-5684
Kato T; Date T; Miyamoto M; Sugiyama M; Tanaka Y; et al.
Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system
11
121819 2005 NOV [15] JOURNAL OF VIROLOGY 79 (21): 13594-13605
Quinkert D; Bartenschlager R; Lohmann V
Quantitative analysis of the hepatitis C virus replication complex
14
1314410 2005 NOV [15] JOURNAL OF VIROLOGY 79 (22): 13963-13973
Cai ZH; Zhang C; Chang KS; Jiang JY; Ahn BC; et al.
Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells
22
1411919 2005 NOV-DEC [NOV 15] REVIEWS IN MEDICAL VIROLOGY 15 (6): 349-350
Mahy BWJ
Therapeutic RNA?
00
1516822 2005 NOV [15] TRENDS IN MICROBIOLOGY 13 (11): 528-534
Seeger C
Salient molecular features of hepatitis C virus revealed
11
161594 2005 DEC 2 JOURNAL OF BIOLOGICAL CHEMISTRY 280 (48): 39802-39808
Domitrovich AM; Felmlee DJ; Siddiqui A
Hepatitis C virus nonstructural proteins inhibit apolipoprotein B100 secretion
00
1712217 2005 DEC 6 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 102 (49): 17539-17540
Freundt EC; Lenardo MJ
Interfering with interferons: Hepatitis C virus counters innate immunity
02
184723 2005 DEC [15] HEPATOLOGY 42 (6): 1264-1269
Berke JM; Moradpour D
Hepatitis C virus comes full circle: Production of recombinant infectious virus in tissue culture
12
191556 2005 DEC [15] JOURNAL OF GENERAL VIROLOGY 86: 3189-3199
Sandrin V; Boulanger P; Penin F; Granier C; Cosset FL; et al.
Assembly of functional hepatitis C virus glycoproteins on infectious pseudoparticles occurs intracellularly and requires concomitant incorporation of E1 and E2 glycoproteins
12
201648 2005 DEC 15 JOURNAL OF IMMUNOLOGY 175 (12): 8226-8235
Lee SH; Kim YK; Kim CS; Seol SK; Kim J; et al.
E2 of hepatitis C virus inhibits apoptosis
12
#LCRNCRNode / Date / Journal / AuthorLCSGCS
2114611 2005 DEC [15] JOURNAL OF VIROLOGY 79 (24): 15525-15536
Griffin S; Clarke D; McCormick C; Rowlands D; Harris M
Signal peptide cleavage and internal targeting signals direct the hepatitis C virus p7 protein to distinct intracellular membranes
00
2213418 2005 DEC 20 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 102 (51): 18544-18549
Rosa D; Saletti G; De Gregorio E; Zorat F; Comar C; et al.
Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders
12
2341831 2006 JAN [15] EMBO REPORTS 7 (1): 14-17
Rinaldi A
The phantom menace
00
2415556 2006 JAN [15] JOURNAL OF VIROLOGY 80 (1): 149-160
Paeshuyse J; Leyssen P; Mabery E; Boddeker N; Vrancken R; et al.
A novel, highly selective inhibitor of pestivirus replication that targets the viral RNA-dependent RNA polymerase
11
2518275 2006 JAN-FEB [JAN 15] REVIEWS IN MEDICAL VIROLOGY 16 (1): 37-48
Graci JD; Cameron CE
Mechanisms of action of ribavirin against distinct viruses
00
2614529 2006 FEB 3 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 340 (1): 200-208
Matsuo E; Tani H; Lim CK; Komoda Y; Okamoto T; et al.
Characterization of HCV-like particles produced in a human hepatoma cell line by a recombinant baculovirus
00
2732970 2006 FEB 14 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 103 (7): 2310-2315
Yi M; Villanueva RA; Thomas DL; Wakita T; Lemon SM
Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells
11
2814233 2006 FEB [15] FASEB JOURNAL 20 (2)
Maillard P; Huby T; Andreo U; Moreau M; Chapman J; et al.
The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins
00
29110535 2006 FEB [15] HEPATOLOGY 43 (2): S207-S220
Pawlotsky JM
Therapy of hepatitis C: From empiricism to eradication
00
3014836 2006 FEB [15] HEPATOLOGY 43 (2): 257-265
Nahmias Y; Casali M; Barbe L; Berthiaume F; Yarmush ML
Liver endothelial cells promote LDL-R expression and the uptake of HCV-like particles in primary rat and human hepatocytes
00
#LCRNCRNode / Date / Journal / AuthorLCSGCS
3113148 2006 FEB [15] JOURNAL OF GENERAL VIROLOGY 87: 323-327
Liu SH; Ansari IH; Das SC; Pattnaik AK
Insertion and deletion analyses identify regions of non-structural protein 5A of Hepatitis C virus that are dispensable for viral genome replication
00
3215752 2006 FEB [15] JOURNAL OF HEPATOLOGY 44 (2): 411-421
McHutchison JG; Bartenschlager R; Patel K; Pawlotsky JM
The face of future hepatitis C antiviral drug development: Recent biological and virologic advances and their translation to drug development and clinical practice
01
3313357 2006 FEB [15] JOURNAL OF VIROLOGY 80 (3): 1181-1190
Nelson HB; Tang HL
Effect of cell growth on hepatitis C virus (HCV) replication and a mechanism of cell confluence-based inhibition of HCV RNA and protein expression
01
3415058 2006 FEB [15] JOURNAL OF VIROLOGY 80 (4): 1734-1741
Tscherne DM; Jones CT; Evans MJ; Lindenbach BD; McKeating JA; et al.
Time-and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry
44
3515159 2006 FEB [15] JOURNAL OF VIROLOGY 80 (4): 1817-1825
Kobayashi M; Bennett MC; Bercot T; Singh IR
Functional analysis of hepatitis C virus envelope proteins, using a cell-cell fusion assay
00
3626644 2006 FEB 17 JOURNAL OF BIOLOGICAL CHEMISTRY 281 (7): 3909-3917
Lavillette D; Bartosch B; Nourrisson D; Verney G; Cosset FL; et al.
Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes
33
3722371 2006 MAR 7 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 103 (10): 3500-3501
Bukh J; Purcell RH
A milestone for hepatitis C virus research: A virus generated in cell culture is fully viable in vivo
00
3832772 2006 MAR 7 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 103 (10): 3805-3809
Lindenbach BD; Meuleman P; Ploss A; Vanwolleghem T; Syder AJ; et al.
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
22
3917553 2006 MAR 9 JOURNAL OF MEDICINAL CHEMISTRY 49 (5): 1693-1705
Koch U; Attenni B; Malancona S; Colarusso S; Conte I; et al.
2-(2-thienyl)-5,6-dihydroxy-4-carboxypyrimidines as inhibitors of the hepatitis C virus NS5B polymerase: Discovery, SAR, modeling, and mutagenesis
00
4015024 2006 MAR 15 ANALYTICAL BIOCHEMISTRY 350 (2): 239-248
Tonary AM; Pezacki JP
Simultaneous quantitative measurement of luciferase reporter activity and cell number in two-and three-dimensional cultures of hepatitis C virus replicons
00
#LCRNCRNode / Date / Journal / AuthorLCSGCS
4114925 2006 MAR [15] ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 50 (3): 1013-1020
Malcolm BA; Liu R; Lahser F; Agrawal S; Belanger B; et al.
SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells
00
42419627 2006 MAR [15] ANTIVIRAL RESEARCH 69 (3): 129-141
Thimme R; Lohmann V; Weber F
A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus
00
4349734 2006 MAR [15] GENE THERAPY 13 (6): 563-575
Grimm D; Kay MA
Therapeutic short hairpin RNA expression in the liver: viral targets and vectors
00
4414837 2006 MAR [15] HEPATOLOGY 43 (3): 592-601
Tarr AW; Owsianka AM; Timms JM; McClure CP; Brown RJP; et al.
Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33
00
4517543 2006 MAR [15] INFECTIOUS DISEASE CLINICS OF NORTH AMERICA 20 (1): 81-+
Glenn JS
Molecular virology of the hepatitis C virus: Implication for novel therapies
00
4614460 2006 MAR [15] JOURNAL OF VIROLOGY 80 (6): 2832-2841
Rouille Y; Helle F; Delgrange D; Roingeard P; Voisset U; et al.
Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus
11
4726345 2006 APR 14 JOURNAL OF BIOLOGICAL CHEMISTRY 281 (15): 9833-9836
Appel N; Schaller T; Penin F; Bartenschlager R
From structure to function: New insights into hepatitis C virus RNA replication
00
4825532 2006 APR [15] EUROPEAN JOURNAL OF IMMUNOLOGY 36 (4): 919-929
Crotta S; Ronconi V; Ulivieri C; Baldari CT; Valiente NM; et al.
Cytoskeleton rearrangement induced by tetraspanin engagement modulates the activation of T and NK cells
00
4914638 2006 APR [15] HEPATOLOGY 43 (4): 761-770
Paeshuyse J; Kaul A; De Clercq E; Rosenwirth B; Dumont JM; et al.
The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro
00
5012249 2006 APR [15] JOURNAL OF GENERAL VIROLOGY 87: 855-860
Ait-Goughoulte M; Hourioux C; Patient R; Trassard S; Brand D; et al.
Core protein cleavage by signal peptide peptidase is required for hepatitis C virus-like particle assembly
00
#LCRNCRNode / Date / Journal / AuthorLCSGCS
5113550 2006 APR [15] JOURNAL OF GENERAL VIROLOGY 87: 861-871
Chapel C; Garcia C; Roingeard P; Zitzmann N; Dubuisson J; et al.
Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles
00
5227261 2006 APR [15] JOURNAL OF VIROLOGY 80 (7): 3332-3340
Shimakami T; Honda M; Kusakawa T; Murata T; Shimotohno K; et al.
Effect of hepatitis C virus (HCV) NS5B-nucleolin interaction on HCV replication with HCV subgenomic replicon
00
5325754 2006 APR 20 JOURNAL OF MEDICINAL CHEMISTRY 49 (8): 2621-2627
Tabarrini O; Manfroni G; Fravolini A; Cecchetti V; Sabatini S; et al.
Synthesis and anti-BVDV activity of acridones as new potential antiviral agents
00
5413255 2006 MAY 4 JOURNAL OF MEDICINAL CHEMISTRY 49 (9): 2750-2757
Bogen SL; Arasappan A; Bennett F; Chen K; Jao E; et al.
Discovery of SCH446211 (SCH6): A new ketoamide inhibitor of the HCV NS3 serine protease and HCV subgenomic RNA replication
00
5533573 2006 MAY 9 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 103 (19): 7408-7413
Pietschmann T; Kaul A; Koutsoudakis G; Shavinskaya A; Kallis S; et al.
Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras
00
5624926 2006 MAY [15] ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 50 (5): 1813-1822
Lin K; Perni RB; Kwong AD; Lin C
VX-950, a novel hepatitis C virus (HCV) NS34A protease inhibitor, exhibits potent antiviral activities in HCV replicon cells
00
5713630 2006 MAY [15] CURRENT OPINION IN GASTROENTEROLOGY 22 (3): 193-197
Moseley RH
Liver and biliary tract disorders
00
5842739 2006 MAY [15] HEPATOLOGY 43 (5): 903-905
Dreux M; Cosset FL
HCV and lipoproteins: Is oxLDL an Achilles' heel of the Trojan horse?
00
5914640 2006 MAY [15] HEPATOLOGY 43 (5): 932-942
von Hahn T; Lindenbach BD; Boullier A; Quehenberger O; Paulson M; et al.
Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells
11
6019451 2006 MAY [15] JOURNAL OF GENERAL VIROLOGY 87: 1075-1084
Cocquerel L; Voisset C; Dubuisson J
Hepatitis C virus entry: potential receptors and their biological functions
00
#LCRNCRNode / Date / Journal / AuthorLCSGCS
6123462 2006 MAY [15] JOURNAL OF VIROLOGY 80 (9): 4510-4520
Ishii N; Watashi K; Hishiki T; Goto K; Inoue D; et al.
Diverse effects of cyclosporine on hepatitis C virus strain replication
00
6233363 2006 MAY [15] JOURNAL OF VIROLOGY 80 (9): 4633-4639
Kanda T; Basu A; Steele R; Wakita T; Ryerse JS; et al.
Generation of infectious hepatitis C virus in immortalized human hepatocytes
00
6314764 2006 MAY [15] JOURNAL OF VIROLOGY 80 (10): 4940-4948
Bertaux C; Dragic T
Different domains of CD81 mediate distinct stages of hepatitis C virus pseudoparticle entry
00
6422874 2006 MAY 30 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 103 (22): 8499-8504
Cheng G; Zhong J; Chisari FV
Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms
00
6529867 2006 JUN 9 MOLECULAR CELL 22 (5): 561-569
Meylan E; Tschopp J
Toll-like receptors and RNA helicases: Two parallel ways to trigger antiviral responses
00
6626841 2006 JUN [15] HEPATOLOGY 43 (6): 1326-1336
Fang X; Zeisel MB; Wilpert J; Gissler B; Thimme R; et al.
Host cell responses induced by hepatitis C virus binding
00
6714547 2006 JUN [15] JOURNAL OF CLINICAL VIROLOGY 36 (2): 87-94
Stauber RE; Stadlbauer V
Novel approaches for therapy of chronic hepatitis C
00
6825665 2006 JUN [15] JOURNAL OF VIROLOGY 80 (11): 5308-5320
Koutsoudakis G; Kaul A; Steinmann E; Kallis S; Lohmann V; et al.
Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses
00
6926669 2006 JUN [15] ONCOGENE 25 (27): 3857-3865
Romano PR; McCallus DE; Pachuk CJ
RNA interference-mediated prevention and therapy for hepatocellular carcinoma
00
70122128 2006 [JUN 30] ANTIVIRAL THERAPY 11 (3): 273-287
Trepanier JB; Tanner JE; Alfieri C
Oligonucleotide-based therapeutic options against hepatitis C virus infection
00
#LCRNCRNode / Date / Journal / AuthorLCSGCS
7117768 2006 [JUN 30] NUCLEIC ACIDS RESEARCH 34 (9): 2618-2633
Ivanyi-Nagy R; Kanevsky I; Gabus C; Lavergne JP; Ficheux D; et al.
Analysis of hepatitis C virus RNA dimerization and core-RNA interactions
00
7227846 2006 JUL 7 JOURNAL OF BIOLOGICAL CHEMISTRY 281 (27): 18285-18295
Dreux M; Pietschmann T; Granier C; Voisset C; Ricard-Blum S; et al.
High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI
00
7325323 2006 JUL [15] AMERICAN JOURNAL OF PATHOLOGY 169 (1): 200-208
Lai WK; Sun PJ; Zhang J; Jennings A; Lalor PF; et al.
Expression of DC-SIGN and DC-SIGNR on human sinusoidal endothelium - A role for capturing hepatitis C virus particles
00
7422642 2006 JUL [15] HEPATOLOGY 44 (1): 117-125
Ikeda M; Abe K; Yamada M; Dansako H; Naka K; et al.
Different anti-HCV profiles of statins and their potential for combination therapy with interferon
00
7545966 2006 JUL [15] JOURNAL OF VIROLOGY 80 (14): 6964-6972
Blanchard E; Belouzard S; Goueslain L; Wakita T; Dubuisson J; et al.
Hepatitis C virus entry depends on clathrin-mediated endocytosis
00

Generated by HistCite 2006.08.02